Blood Pressure During Rate Control in Patients With Tachycardic Atrial Fibrillation at the Emergency Department

• Conditions: Atrial Fibrillation

• Registration Number: NCT04005482
• Lead Sponsor: Medical University of Vienna

Brief Summary

The aim of this study is to analyse blood pressure during rate control therapy in patients with tachycardic atrial fibrillation in a real-world emergency cohort.

Detailed Description

Atrial fibrillation (AF) is the primary clinical problem in 3.3% to 10.0 % emergency department (ED) admissions. Rate control is an integral part of the management of symptomatic tachycardic AF patients.

According to the recent guidelines beta-blockers, digoxin, the calcium channel blockers diltiazem and verapamil, amiodarone or combination therapy should be considered for rate control. Haemodynamic side-effects in particular hypotension may occur. Heart rate and blood pressure behavior in an ED population during rate control therapy in patients with tachycardic atrial fibrillation will be analysed.

Study Timeline

• Study First Submitted: 2019-06-29
• Study First Submitted QC: 2019-07-01
• Study First Posted: 2019-07-02
• Status Verified: 2019-09
• Last Update Submitted: 2019-09-16
• Last Update Posted: 2019-09-17
• Study Start: 2019-09-20
• Primary Completion: 2021-07-20
• Study Completion: 2021-07-20

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

• Age > 18 years
• Atrial fibrillation or atrial flutter and heart rate ≥ 110 bpm
• Indication for rate control
• Informed consent

Read More

Exclusion Criteria

• Inclusion criteria not met

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean and maximum blood pressure difference between before (baseline) and during/after medication.	20th July 2019 to 20th July 2021